New parameters to monitor the progression of diabetic nephropathy

U. Di Mario, S. Morano, A. Cancelli, S. Bacci, S. Frontoni, P. Pietravalle, S. Gambardella, D. Andreani

Research output: Contribution to journalArticle

Abstract

The possible differential elimination of the anionic IgG4 and of the other cationic IgG molecules whose pH differs but whose other characteristics are similar, has been hypothesized as a possibly useful parameter in monitoring preclinical diabetic nephropathy. An enzyme-linked immunosorbent assay method has been developed, based on a sandwich technique with subclass-specific antiimmunoglobulin monoclonal antibodies, which detects about 2 ng/mL IgG4. A sensitive radioimmunoassay method has been used to detect IgG. Normoalbuminuric, microalbuminuric, and macroalbuminuric patients, together with normal control subjects, were included in the cross-sectional study. Whereas IgG levels were elevated, as expected, in macroalbuminuric patients, it was interesting to note that IgG4, but not total IgG, levels were elevated in microalbuminuric patients. The IgG4/IgG ratio was increased almost to the same extent in microalbuminuric and macroalbuminuric patients. These findings are strongly in favor of the selective elimination of the acid medium-sized protein, IgG4, in incipient diabetic nephropathy. The measurement of immunoglobulin subclasses in the urine appears to be a promising parameter to characterize and subgroup diabetic patients with preclinical diabetic nephropathy.

Original languageEnglish
Pages (from-to)45-48
Number of pages4
JournalAmerican Journal of Kidney Diseases
Volume13
Issue number1
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'New parameters to monitor the progression of diabetic nephropathy'. Together they form a unique fingerprint.

  • Cite this

    Di Mario, U., Morano, S., Cancelli, A., Bacci, S., Frontoni, S., Pietravalle, P., Gambardella, S., & Andreani, D. (1989). New parameters to monitor the progression of diabetic nephropathy. American Journal of Kidney Diseases, 13(1), 45-48.